Loading clinical trials...
Loading clinical trials...
Feasibility Study to Evaluate the Initial Safety and Effectiveness of TRUFILL n-BCA Liquid Embolic System in Middle Meningeal Artery Embolization for the Preventive Treatment of Refractory Chronic Migraine
Conditions
Interventions
Middle Meningeal Artery embolization
Locations
9
United States
Barrow Neurological Institute at St. Joseph's Hospital
Phoenix, Arizona, United States
John Muir Physician Network Clin. Research Center
Walnut Creek, California, United States
Hartford Hospital
Hartford, Connecticut, United States
University of Buffalo Medical Center
Buffalo, New York, United States
Mount Sinai
New York, New York, United States
Stony Brook University Medical Center
Stony Brook, New York, United States
Start Date
April 23, 2025
Primary Completion Date
December 25, 2028
Completion Date
May 15, 2029
Last Updated
April 17, 2026
NCT06241313
NCT06641466
NCT07018713
NCT04715685
NCT07476053
NCT05734625
Lead Sponsor
Cerenovus, Part of DePuy Synthes Products, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions